Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease.

Katz MG, Ohad DG, Putter P, Shtraizent N, Shahar E, Tal S, Eliyahu E

Open source

DOI
10.3389/fvets.2024.1415030
Published
2024
Container
Frontiers in veterinary science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fvets.2024.1415030,
  title = {Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease.},
  author = {Katz MG and Ohad DG and Putter P and Shtraizent N and Shahar E and Tal S and Eliyahu E},
  year = {2024},
  journal = {Frontiers in veterinary science},
  doi = {10.3389/fvets.2024.1415030},
  url = {https://doi.org/10.3389/fvets.2024.1415030}
}

RIS

TY  - JOUR
TI  - Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease.
AU  - Katz MG
AU  - Ohad DG
AU  - Putter P
AU  - Shtraizent N
AU  - Shahar E
AU  - Tal S
AU  - Eliyahu E
PY  - 2024
JO  - Frontiers in veterinary science
DO  - 10.3389/fvets.2024.1415030
UR  - https://doi.org/10.3389/fvets.2024.1415030
ER  - 

APA

MG, K., DG, O., P, P., N, S., E, S., S, T., & E, E. (2024). Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease.. Frontiers in veterinary science. https://doi.org/10.3389/fvets.2024.1415030

Source records